DOI: 10.1055/s-00049561

South Asian Journal of Cancer

Issue 04 · Volume 04 · October 2015 DOI: 10.1055/s-010-50051

MOLECULAR ONCOLOGY : Original Article

155
Sarkar, Santanu; Kanoi, Aditya; Bain, Jayanta; Gayen, Rajarshi; Das, Kashi Nath: Correlation between cyclin D1 expression and standard clinicopathological variables in invasive breast cancer in Eastern India
160
Shemin, K. M. Zuhara; Smitha, N. V.; Jojo, Annie; Vijaykumar, D. K.: Molecular classification and prognostication of 300 node-negative breast cancer cases: A tertiary care experience

Letter to the Editor

159
Rana, S.; Pokharel, S.: Radiobiological case study of volumetric modulated arc therapy planning techniques for treatment of low-risk prostate cancer in patients with bilateral hip prostheses
182
Verbelen, Hanne; Gebruers, Nick; Tjalma, Wiebren: Late effects of cancer treatment in breast cancer survivors

NEURO ONCOLOGY : Review Article

163
Roy, Sanjoy; Lahiri, Debarshi; Maji, Tapas; Biswas, Jaydip: Recurrent Glioblastoma: Where we stand

NEURO ONCOLOGY : Original Article

174
Mallick, Supriya; Gandhi, Ajeet Kumar; Benson, Rony; Sharma, Daya Nand; Haresh, Kunhi Parambath; Gupta, Subhash; Julka, Pramod Kumar; Rath, Goura Kisor: Outcomes of adult medulloblastoma treated with a multimodality approach: A tertiary cancer center experience

HEAD AND NECK CANCER : Review Article

179
Parkar, Sujal Mitul; Shah, Mihir N.: A relationship between quality-of-life and head and neck cancer: A systemic review

HEAD AND NECK CANCER : Original Article

183
Gupta, Karan; Panda, Naresh K; Bakshi, Jaimanti; Das, Ashim: To evaluate disparity between clinical and pathological tumor-node-metastasis staging in oral cavity squamous cell carcinoma patients and its impact on overall survival: An institutional study

MYELODYSPLASTIC SYNDROME : Review Article

186
Taran, Sachi Jain; Taran, Rakesh: Role of iron chelation in improving survival: An integral part of current therapy for myelodysplastic syndromes

None

188
Tin, Sim Sai; Wiwanitkit, Viroj: Palliative low dose fortnightly methotrexate in oral cancer